Skip to main content
Clinical Trials/NL-OMON52283
NL-OMON52283
Not yet recruiting
Not Applicable

Reperfusion of the brain after endovascular thrombectomy for ischemic stroke: development of novel prognostic imaging biomarkers using magnetic resonance imaging - Reperfuse

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Erasmus MC, Universitair Medisch Centrum Rotterdam
Enrollment
80
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- A clinical diagnosis of acute ischemic stroke
  • \- Age 18 years or older
  • \- Treated with EVT for a large vessel occlusion of the anterior circulation
  • (intracranial carotid artery or middle cerebral artery (M1 segment or M2
  • segment) confirmed by neuroimaging (CTA or MRA) resulting in a successful
  • recanalization (defined as eTICI \>\= 2B)
  • \- Written informed consent obtained

Exclusion Criteria

  • \- Pre\-stroke disability which interferes with assessment of functional outcome
  • at 90 days, i.e. mRS \>2
  • \- Contraindication(s) for MRI (e.g. claustrophobia, pacemaker, metallic
  • implant, known contrast allergy)
  • \- Clinical condition unsuited for MRI imaging or prolonged stay at the
  • Radiology department (e.g. agitation and restlessness, neurologic deterioration)
  • \- Use of general anesthesia during EVT

Outcomes

Primary Outcomes

Not specified

Similar Trials